Influence
July 16, 2020

Regenstrief research scientist shares ICU experience during Side Effects COVID-19 panel

Regenstrief research scientist Sikandar Khan, D.O., shared his perspective from working in the intensive care unit (ICU) in the midst of the COVID-19 outbreak during a panel hosted by Side Effects Public Media and Indiana Public Broadcasting.

Dr. Khan has been treating patients in the ICU at Indiana University Health Methodist Hospital throughout the COVID-19 pandemic. He spoke about how data has helped guide decisions in the ICU, allowing clinicians to anticipate surges in cases and plan for equipment and personnel needs.

He also talked about the potentially long recovery COVID-19 survivors face. Patients who need intensive care, especially those who are put on ventilators, are at risk for post intensive care syndrome. This can affect the patient’s body as well as the mind. Dr. Khan said he and his colleagues are closely watching to see what recovery will look like for COVID-19 patients.

Dr. Khan also lauded his colleagues for adapting to the stressful situation and their tireless work to take care of patients. He urged everyone to continue taking precautions, including social distancing and wearing masks.

Watch the entire panel here

Related News

Prevalence of Unrecognized Cognitive Impairment in Federally Qualified Health Centers

Published in the journal JAMA Network Open. Here is a link to the article. Regenstrief Institute authors: Nicole Fowler,

Brian Dixon, PhD, MPA

Brian Dixon named director of biomedical informatics at Regenstrief Institute

A trailblazer in the burgeoning fields of population and public health informatics, Brian Dixon, PhD, MPA, has been named

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Indianapolis – Researchers from Indiana University Indianapolis, Regenstrief Institute and the IU School of Medicine’s Indiana Alzheimer’s Disease Research

Malaz Boustani, M.D., MPH, Paul Dexter, M.D., Zina Ben Miled, PhD, M.S.

Dementia risk prediction: Zero-minute assessment at less than a dollar cost

Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study